The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 331:1711-1712 December 22, 1994 Number 25
NextNext

Drug-Induced End-Stage Renal Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-PubMed Citation
Chronic tubulointerstitial nephritis and nephritis of unknown origin account for 15 to 30 percent of the cases of end-stage renal disease (ESRD) in the United States and Europe. A substantial but as yet undetermined proportion of these cases may be due to drug-induced nephrotoxicity. Evaluating the role of nephrotoxic drugs is a critical health care issue because of the opportunity to prevent ESRD. In 1953 Spuhler and Zollinger1 suggested that the prolonged ingestion of analgesic drugs could cause tubulointerstitial nephritis (so-called analgesic nephropathy), and subsequently many studies confirmed their hypothesis. As a consequence, phenacetin was withdrawn from the market. The . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.